Antimicrobial Stewardship Practices in Outpatient Parenteral Antimicrobial Therapy Programs in the United States

被引:0
|
作者
Azimi, Sara F. [1 ]
Golnabi, Esther [2 ]
Mynatt, Ryan P. [3 ]
Burgess, Donna [3 ]
Logan, Ashley [3 ]
Wrenn, Rebekah H. [4 ]
Mercado, Michael Parisi [5 ]
Boeser, Kimberly [6 ]
Plauche, Ardath [7 ]
Sexton, Mary Elizabeth [8 ]
Walraven, Carla [1 ]
机构
[1] Univ New Mexico Hosp, Dept Pharm, 2211 Lomas Blvd NE, Albuquerque, NM 87106 USA
[2] Univ Texas Southwestern Med Ctr, Pharm Dept, Dallas, TX USA
[3] Univ Kentucky HealthCare, Dept Pharm Serv, Lexington, KY USA
[4] Duke Ctr Antimicrobial Stewardship & Infect Preven, Dept Pharm, Durham, NC USA
[5] Ohio State Univ, Wexner Med Ctr, Dept Pharm, Columbus, OH USA
[6] M Hlth Fairview Univ Minnesota, Med Ctr, Dept Pharm, Minneapolis, MN USA
[7] Mem Hermann Hlth Syst, Dept Pharm, Houston, TX USA
[8] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 07期
关键词
Antimicrobial stewardship; Joint Commission; OPAT; Survey; Metrics;
D O I
10.1093/ofid/ofae347
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Outpatient parenteral antimicrobial therapy (OPAT) regimens typically prioritize ease of antimicrobial administration, tolerability, safety, and accessibility over using the narrowest-spectrum antimicrobial. In light of this, OPAT providers often utilize different techniques to promote antimicrobial stewardship (AMS) in their OPAT programs. This study aims to characterize the AMS practices of OPAT programs across the United States that might meet The Joint Commission requirements for outpatient AMS metrics.Methods This is a cross-sectional electronic survey of the Vizient AMS network. A total of 95 possible questions were designed to inquire about demographics, OPAT program structure, AMS initiatives, performance metrics, and resources.Results Seventy-four survey responses were received, with 58 (78.4%) of the respondents indicating their institution offered OPAT services. Respondents reported having at least 1 AMS protocol and tracking at least 1 metric in 91% and 74% of OPAT programs, respectively. Only 40% of programs reported billing for OPAT-related services. Approximately 45% of respondents disagreed or strongly disagreed that their OPAT program had the resources needed to care for the population it serves. Respondents identified data analytics (69%), funding for expansion of services (67%), and pharmacists (62%) as resources of greatest need for their OPAT programs.Conclusions This survey collectively describes the AMS practices currently employed by OPAT programs across the United States. The results provide specific examples of AMS initiatives, metrics, and resources that institutions may reference to advance the practices of their OPAT programs to meet The Joint Commission Outpatient Antimicrobial Stewardship standards. This cross-sectional survey describes the antimicrobial stewardship (AMS) practices currently employed by outpatient parenteral antimicrobial therapy (OPAT) programs across the United States. Institutions may reference the results to advance the AMS practices of their OPAT programs to meet The Joint Commission Outpatient AMS standards.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
    Mahoney, Monica V.
    Childs-Kean, Lindsey M.
    Khan, Parisa
    Rivera, Christina G.
    Stevens, Ryan W.
    Ryan, Keenan L.
    CURRENT INFECTIOUS DISEASE REPORTS, 2021, 23 (12)
  • [2] Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists
    Gilchrist, M.
    Seaton, R. A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) : 965 - 970
  • [3] Outpatient parenteral antimicrobial therapy in pediatrics: the role of antimicrobial stewardship
    Trisno, Daniel J.
    Puckett, Lauren
    Jensen, Alexandria
    Schwenk, Hayden T.
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):
  • [4] Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy
    Monica V. Mahoney
    Lindsey M. Childs-Kean
    Parisa Khan
    Christina G. Rivera
    Ryan W. Stevens
    Keenan L. Ryan
    Current Infectious Disease Reports, 2021, 23
  • [5] Outpatient Parenteral Antimicrobial Therapy in Pediatrics: An Opportunity to Expand Antimicrobial Stewardship
    Knackstedt, Elizabeth D.
    Stockmann, Chris
    Davis, Carly R.
    Thorell, Emily A.
    Pavia, Andrew T.
    Hersh, Adam L.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (02): : 222 - 224
  • [6] Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?
    Ester Steffens
    Charlotte Quintens
    Inge Derdelinckx
    Willy E. Peetermans
    Johan Van Eldere
    Isabel Spriet
    Annette Schuermans
    Infection, 2019, 47 : 169 - 181
  • [7] Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy
    Hersh, Adam L.
    Olson, Jared
    Stockmann, Chris
    Thorell, Emily A.
    Knackstedt, Elizabeth D.
    Esquibel, Lawanda
    Sanderson, Susan
    Pavia, Andrew T.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (02) : E34 - E36
  • [8] Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?
    Steffens, Ester
    Quintens, Charlotte
    Derdelinckx, Inge
    Peetermans, Willy E.
    Van Eldere, Johan
    Spriet, Isabel
    Schuermans, Annette
    INFECTION, 2019, 47 (02) : 169 - 181
  • [9] Appropriateness and Safety of Outpatient Parenteral Antimicrobial Therapy in Children: Opportunities for Pediatric Antimicrobial Stewardship
    Akar, Arezou
    Singh, Nalini
    Hyun, David Y.
    CLINICAL PEDIATRICS, 2014, 53 (10) : 1000 - 1003
  • [10] Next Step, Outpatient Antimicrobial Therapy Programs as a Tool of Stewardship Programs
    Eduardo Lopez-Cortes, Luis
    Luque, Rafael
    Miguel Cisneros, Jose
    Fraile-Ramos, Elena
    Manuel Carmona-Caballero, Juan
    Praena, Julia
    Victoria Gil-Navarro, Maria
    Angel Pazos, Jose
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (12) : 2155 - 2155